1/11 Shocking and terrible news, possibly for the entire world. Molnupiravir works by inducing mutations in the virus. The potential danger is obvious, and Merck has not provided any reassuring data on this.
2/11 Perhaps most shocking is that MOV was approved when it's not at all clear that it will have any benefit at all for the people taking it. MOV only showed any efficacy at all in the pre-Delta era. nature.com/articles/d4158…
3/11 The @Nature article above actually understates the matter. In the second part of the trial, from Aug-Oct, there was actually a 32% higher rate of hospitalization in the MOV group than in the placebo group (6.2% vs 4.7%).
4/11 Merck had no explanation for why molnupiravir appeared to be worse than useless in the last half of their trial. However, it seems likely Delta rendered it useless.
5/11 Why was molnupiravir useless—or perhaps even harmful—against Delta? Apparently, no one at the FDA thought to ask this question. Could it be due to Delta's rapid replication? If so, MOV will likely prove useless against the rapidly replicating Omicron.
6/11 As @jpogue1 points out, the hospitalization rate in the placebo group in the interim analysis was a real outlier and should've raised eyebrows.
7/11 Merck showed that MOV decreased viral load 100-fold in hamsters, but this is not reassuring at all. That means there was still a ton of mutated virus present in the hamsters.
8/11 But the situation is actually substantially worse that the hamster data show. According to Merck's own FDA presentation, the decrease in viral load by days 3 & 5 in the MOV group compared to the placebo group is a modest 42 and 53%. It gets worse. fda.gov/media/154472/d…
9/11 The human trial data show no difference in viral RNA titers at day 29 in treatment group compared to placebo. Figure buried in supplementary data. Perhaps I'm misinterpreting something, but this doesn't seem reassuring to me.
10/11 A full course of molnupiravir requires taking 40 pills over 5 days—not an easy regimen. It is 100% certain that many patients—many of whom would improve even without treatment—will not finish the full course. The FDA freely admits the danger in this.
11/11 Finally, while it is probably a coincidence, it is noteworthy that of the 173 molnupiravir trial sites, four were in Gauteng Province, South Africa, the cite of the first major Omicron outbreak. There were eight other South African sites also. clinicaltrials.gov/ct2/show/NCT04…
12/ When I made this thread, I hadn’t read the article below by @WmHaseltine, former professor at Harvard Medical School & Harvard School of Public Health & founder of two Harvard research departments (biochemical pharmacology & human retrovirology). forbes.com/sites/williamh…
13/ Haseltine points out that at the clinical trial sites in South Africa (including 4 in Gauteng), molnupiravir was sometimes used in small doses of exactly the sort expected to induce mutations without clearing the virus from the body—the nightmare scenario.
14/ FDA and Merck both admit that the risk of onward transmission from MOV-treated patients exists if patients do not isolate & complete the 5-day, 40-pill course (or, presumably, take a lower dose). This is guaranteed to happen on a massive scale.
15/ But most worrisome of all, the majority of the mutations found in Omicron are of exactly the type molnupiravir is known to preferentially induce. And the number of mutations in Omicron is consistent with the number observed in other coronaviruses exposed to molnupiravir.
16/ Why in the world was this drug, which might have zero benefit for patients (see tweet #3) and which might unleash a hellish menagerie of variants on the world, approved by the FDA? This is madness. It must be reversed.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Ryan Hisner

Ryan Hisner Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @LongDesertTrain

24 Dec
1/6 At a private gathering of 33 Pfizer-triple-vaccinated health care workers in the Faroe Islands, 21 were infected with Omicron—a superspreading event among 3-dose-vaccinated people. All received dose #3 within 2.5 months of the event. Very discouraging.
medrxiv.org/content/10.110…
2/6 All participants tested negative within 36 hours of the event: five with rapid tests and the other 28 with PCR tests. Median age was 45. Only four of the 21 infected had any comorbidities.
3/6 And very similar to the Oslo Christmas superspreader event (where 79 of 80 infected were symptomatic, with 74 having >3 symptoms), all 21 experienced symptoms. There is virtually no asymptomatic infection with Omicron it seems.
Read 6 tweets
23 Dec
1/4 Must-read 🧵. Molnupiravir could be a catastrophe, breeding a nightmarish panoply of variants. Approval would be insane.

"MOV approval is most momentous decision the FDA will make in this epidemic, maybe in FDA history, maybe even in the entire history of pharmaceuticals."
2/4 Molnupiravir works by causing SARS-CoV-2 to undergo so many mutations that it ceases to function. Except it doesn't always work. And when it doesn't, virus with potentially beneficial mutations could survive, be passed on, and haunt the world.
3/4 It's not even clear if molnupiravir works at all—in the Delta era phase of its trial, it proved almost totally useless. Perhaps it doesn't work against rapidly replicating variants like Delta & Omicron. nature.com/articles/d4158…
Read 5 tweets
17 Dec
1/ Can't put it better than @micah_arsham does here. The CDC treats the public like 1st-graders. Their job is to inform & advise the public, warning of any imminent dangers, & they've utterly failed. People will be blind-sided, with grim consequences.
2/ As long as the CDC crafts their messaging for political purposes, with a greater concern for shaping public attitudes and manipulating public behavior than telling the unvarnished truth, they will not regain public trust. @michaelmina_lab said it well:
3/ John Barry, author of The Great Influenza, on the *fundamental lesson* of the 1918 pandemic:
"Those in authority must retain the public’s trust. The way to do that is to distort nothing, to put the best face on nothing, to try to manipulate no one"
rochester.edu/newscenter/his…
Read 12 tweets
16 Dec
1/8 Maybe the most well-designed antibody study on Omicron yet. The 🧵 is very well written & the figures are the clearest & best I've seen. Awesome work. Takeaways:

3-dose mRNA > Infection + mRNA >>>> Recent 2-dose mRNA

Moderna > Pfizer >>>> natural infection or J&J
2/8 We already knew J&J primary vaccination was much inferior to either mRNA shot, but this study indicates J&J inferiority remains even after boosting with mRNA, which is troubling.
3/8 Excellent, comprehensive, and enlightening thread on this subject below by @michaelzlin. He makes the case that J&J recipients need 2 mRNA shots, & I don't see how anyone could disagree. Lots of other great insights here as well. Highly recommended.
Read 8 tweets
15 Dec
1/5 Another lab study showing extreme Omicron evasion of NAbs—33-44x reduction for mRNA & AZ. Zero detectable neutralization for J&J, Sputnik, Sinopharm, and—crucially—a majority of convalescents. Infection + mRNA vaccination, on the other hand, holds up well. h/t @dgurdasani1
2/5 Seven out of the eight monoclonal antibody (MAb) treatments currently in use are rendered useless by Omicron. The other (sotrovimab) has 3-fold reduced neutralization vs Omicron. Note: this study used VSV pseudovirus expressing Omicron S protein, not live virus.
3/5 ACE2 affinity increased compared to ancestral SARS-CoV-2, though still lower than that seen in Alpha. No info on Delta, though in silico analysis estimates Omicron binds more tightly than Delta. biorxiv.org/content/10.110…
Read 5 tweets
14 Dec
1/4 We're about to get a preview of what's going to happen with climate change in coming decades. You cannot wait until hospitals are overwhelmed to take action. It's too late.

Similarly, if you wait until climate catastrophe is upon us, the game is up. You waited far too long. Image
2/4 I think few people understand that even if we were to begin dramatically cutting CO2 emissions today & go zero carbon by, say, 2040, the world would continue to warm for some time, & the already severe climate change effects would continue to worsen.

npr.org/2021/04/14/981… Image
3/4 The parallels with Covid don't end there. One likely reason we see such pathetically insufficient action on climate change is that the worst costs will be borne by the poor. And inhabitants of poor countries don't get to vote in rich-country elections. Image
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(